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LETTER TO THE EDITOR
On the age-dependent association between cancer of the breast and
endometrium
Sir - In their recent paper on their follow-up (cohort) study
of60,065 newly diagnosed breast cancer patients, Adami et al.
(1987) reported that 260 endometrial cancers had been
diagnosed after the breast cancer diagnosis compared to an
expected number, based on national rates, of 151.1 (relative
risk=260/151.1 = 1.72). This relative risk for the subsequent
incidence of endometrial cancer in breast cancer patients
increased from 0.95 in patients diagnosed with breast cancer
before age 40 to 2.47 in patients diagnosed at 80 years of age
or older. The authors go on from this to state that 'there is
no obvious common risk factor related to reproductive life
which could give a reasonable explanation for [this observed]
age-dependent association between cancer of the breast and
cancer of the endometrium', and imply that this age
dependence is evidence against the 'traditional... paradigm'
of seeking the causes of (and link between) these two cancers
in terms of 'hormonal expressions of characteristics of
reproductive life or... dietary habits'. Their results are,
however, in good agreement with what we would predict
from our current understanding of the (hormonal)
epidemiology of these two cancers.
There are a number of well-established risk factors for
endometrial cancer. Low parity, late menopause and
oestrogen replacement therapy (ERT) all increase the risk of
endometrial cancer, while use of combination-type oral
contraceptives (COCs) decreases the risk of the disease [see
Kelsey et al. (1982) and Henderson et al. (1982) for
references]. Obesity is a major risk factor both in pre-
menopausal and post-menopausal women [see La Vecchia et
al. (1982) and Henderson et al. (1983) for references]. These
risk factors are all explicable in terms of the 'unopposed
oestrogen hypothesis' for endometrial cancer (Siiteri, 1978;
Nisker et al., 1980; Henderson et al., 1982).
Late age at first birth, late age at menopause and use of
ERT all increase the risk of breast cancer (Thomas, 1984;
Pike & Ross, 1984). We noted above that two of these three
breast cancer risk factors, viz. late menopause and ERT, are
also risk factors for endometrial cancer; late first birth is
too, since late first birth is correlated with low parity. COC
use does not, however, protect against breast cancer, and
may in some circumstances increase the risk of breast cancer
(McPherson & Drife, 1986). The sharp distinction between
the protective effect of COC use against endometrial cancer
and the lack of any such effect on breast cancer risk clearly
shows that the endocrinology of endometrial cancer and
breast cancer are not the same. Most important for an
understanding of the results of Adami et al. (1987) is the
finding that obesity is only associated with an increased risk
of breast cancer in older post-menopausal women (Kelsey et
al., 1981; Lubin et al., 1985). In pre-menopausal women
obesity has been found, in fact, to be associated with a
decreased risk of breast cancer (Willett et al., 1985).
In the pre-menopausal period obesity acts contrariwise as
a risk factor in endometrial cancer and breast cancer. Pre-
menopausal breast cancer patients will tend to be of low
parity but non-obese, so that their risk of endometrial cancer
will probably be little different from expected as their low
parity will slightly increase their risk while their non-obesity
A letter in similar vein to that of Key and Pike has also been
received from Dr F. de Waard, Dept. of Epidemiology, Rijsinstituut
voor Volksgezondheid en Milieuhygiene, The Netherlands.
will decrease it. Post-menopausal breast cancer patients will
tend to be of low parity and of late menopause, and to be
obese: their risk of endometrial cancer will be increased
(relative to expected) on all counts. The association of breast
cancer with obesity only becomes clear five to ten years after
menopause (Kelsey et al., 1981; Lubin et al., 1985) when the
protective effect evident in the pre-menopausal period has
had time to be reversed, so that the greatly increased risk of
endometrial cancer associated with obesity will become
evident only in older post-menopausal breast cancer patients.
This is precisely what Adami et al. (1987) observed.
It may be argued that the above reasoning will not hold in
Sweden because Adami et al. (1977) did not find any
relationship between weight and breast cancer in post-
menopausal Swedish women. We have no explanation for
their negative results, nor for the fact that Adami et al.
(1978) also reported finding no significant relationship
between any reproductive factor and risk of breast cancer in
their study population. However, since the study we are
discussing here (Adami et al., 1987) has no data on body
weight, we feel that it is reasonable to explain the results in
terms of our general understanding of breast cancer.
Yours etc.,
T. Key and M.C. Pike,
ICRF Cancer Epidemiology Unit,
Gibson Building,
Radcliffe Infirmary,
Oxford OX2 6HE, UK.
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Dr Adami & colleagues reply:
Sir, - We appreciate the response to our somewhat
provocative challenge of the 'general understanding' of
breast and endometrial cancer and have read the letter of
Drs Key and Pike with great interest. We should like to
offer two comments. The first is a more general one, which
concerns different approaches to dealing with a large amount
of complex and contradictory data. The second, more
specific comment refers to what we actually know so far
about the pattern of risk factors for breast cancer in the
population studied.
Risk factors for cancer of the endometrium and of the
breast have been studied extensively during the last 15 to 20
years. Numerous associations have been revealed and those
which have emerged with a reasonable degree of consistency
are often referred to as 'well established'. Proceeding from
these associations, some of which are mentioned by Key and
Pike, it has been an attractive goal to find unifying concepts
which link, for example, hormonal derivatives of risk factors
to the probability of development of the disease. Most
hypotheses related to such attempts have the postulate in
common that excess oestrogenic stimulation - for example
due to high circulating levels or increased bioavailability of
oestrogens or insufficient opposing effects of progesterone -
is an important determinant for neoplastic transformation,
particularly if occurring during periods of assumed increased
susceptibility of the target organ.
We agree with Key and Pike that the findings concerning
relations to cancer of the endometrium have been fairly
consistent. However, as far as breast cancer is concerned, the
pattern is frustratingly complex and equivocal. A scrutiny of
available data has shown that the number of studies in
which the association between breast cancer and the
'established risk factors' (e.g. early menarche, low parity, late
first birth, late menopause, short duration of breast feeding)
has been found to be weak or absent is greater than can be
explained by methodological flaws and type II errors. The
resulting uncertainty might be an important reason why the
same factors are actually being studied over and over again.
The lack of association between age at first birth and risk of
breast cancer, which we found at the beginning of this
decade (Adami et al., 1980) has now been confirmed in
Denmark (Ewertz, 1987), Norway (Kvale et al., 1987) and
Sweden (Adami, unpublished).
It is an attractive challenge to attempt to reduce this
confusing pattern to a single unifying hypothesis. The risk
involved in this approach is that when the same risk factors
are selected and approximately the same hypothesis
formulated a number of times, a conformistic situation is
created in which the large inconsistencies in available
evidence become neglected. This will hamper a critical assess-
ment of current research strategies and delay the advance-
ment of more fruitful hypotheses.
More specifically, the 'general understanding' to which
Key and Pike refer, requires that obesity be a risk factor for
postmenopausal breast cancer - and preferably that it
protect against premenopausal occurrence in the Swedish
population. We agree that our previous entirely negative
finding in a relatively small case control study needs to be
confirmed (Adami et al., 1977). Confirmatory results to be
published have emerged, however, from two other sets of
data. Thus, a recent case-control study in women younger
than 45 years (Meirik et al., 1986) failed to reveal any
association between obesity and breast cancer (unpublished).
Likewise, weight was analysed in a nested case-control study
within a cohort of women who had received climacteric
oestrogen treatment (Persson et al., 1983; Bergkvist, 1987).
Using weight below 60kg as a reference, the relative risk in
women who weighed 90kg or more was 0.55 (95%
confidence interval 0.15-2.00). When weight was included as
a continuous variable in a logistic regression model, the
relative risk per kg increase was 0.99 (0.98-1.02) (Bergkvist,
unpublished). These findings are not unique for the Swedish
population. The literature offers in fact only highly equivocal
support for the finding that is crucial for the claim by Key
and Pike, namely that obesity entails an increased risk of
developing breast cancer. And in the positive reports, the
possible confounding effect of dietary patterns needs to be
clarified.
From these considerations, we still believe that critical
judgement of available evidence justifies the conclusion that
the common aetiological mechanisms of breast and endo-
metrial cancer are poorly understood within the general
framework ('the traditional paradigm') of associations with
obesity, the reproductive characteristics and exogenous
hormones.
Yours etc'.
H.-O. Adamil, L. Bergkvist1, I. Persson2 & B. Pettersson3
Departments of 'Surgery; 2Gynecology and Obstetrics
and Oncology and 3Division of Gynecologic Oncology
University Hospital
Uppsala
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